Brief Introduction

Kontour (Xi'an) Medical Technology Co., Ltd. ("KONTOUR MEDICAL") was founded in Xi'An Hi-Tech Industries Development Zone in Shaan'Xi Province in 2005. KONTOUR MEDICAL was listed on the STAR Market (Stock code: 688314) of the Shanghai Stock Exchange on May 18, 2021.

KONTOUR MEDICAL is committed to developing, manufacturing and sale of advanced surgical implant devices applied in Neurosurgery, Cardiovascular surgery and Dentistry surgery. After near 20 years of development, KONTOUR MEDICAL has owned 12 NMPA Class III Implant Devices Licenses. Our PEEK Cranial Repairing System 、PEEK Cranial Fixation System and Sterno PEEK Zip System are first approved domestic implants in China. In addition, KONTOUR MEDICAL self-developed Digital Reconstruction Technique and 3D Remodeling Technique and used them into customized implants, being in a leading position in the industry. KONTOUR MEDICAL has 30 U.S. FDA(510K) cleared devices, and 2 European CE certificates, being expanding our market presence from China to overseas.

Through continuous innovation, we provides the best solution and quality products to the patients and surgeons and aims to become a worldwide leader of implant innovation to improve the health of mankind.

Company Overview

Full name Kontour (Xi'an) Medical Technology Co., Ltd.
Code 688314
Founded 2005-03-14
Listing 2021-05-18
Domicile Xi'an
STAR Theme Biomedicine
CSRC Sector Manufacturing
Has weighted voting rights structure? No



  2020 2019 2018
Earnings Per Share 1.20 1.22 0.52
R&D expenditure as a % of operating revenue 10.30% 7.15% 7.39%
Operating Revenue 164,075,553.99 147,803,874.53 109,503,335.86
Net Income 51,117,903.23 50,740,908.83 21,342,592.32

Income Statement (Unit: RMB mn)

  2020 2019 2018
Operating Revenue 164.08 147.80 109.50
Operating Costs 110.07 99.10 84.92
Operating Income 51.80 60.23 23.41
Pretax Income 58.21 60.31 24.29
Income Tax 7.10 9.57 2.94
Net Income 51.12 50.74 21.34

Balance Sheet(Unit: RMB mn)

  2020 2019 2018
Current Assets-Total 143.32 167.24 81.60
Non-current Assets-Total 148.19 61.08 73.91
Total Assets 291.51 228.32 155.51
Current Liabilities-Total 37.83 28.17 16.96
Non-current Liabilities-Total 10.63 7.66 11.36
Total Liabilities 48.46 35.83 28.32
Stockholder's Equity
Share Capital 43.52 43.52 34.75
Retained Profits 59.35 13.04 21.03
Total Owners' Equity 243.05 192.49 127.19

Cash Flow Statement (Unit: RMB mn)

  2020 2019 2018
Net Cash Flows-Operating 57.83 57.78 22.84
Net Cash Flows-Investing -71.98 19.87 -31.80
Net Cash Flows-Financing -4.18 13.82 -11.17

Top 10 Shareholders

Name No. of Shares Held (mn) % of Shares Held
Liren Hu 28.17 48.54%
Hailong Zhu 5.89 10.15%
Shanghai Hongxi Investment Development Centre Limited Partnership(Limited Partnership) 4.23 7.30%
Xi'an Heying Enterprise Management Consulting Partnership (Limited Partnership) 2.72 4.69%
Huatai Kontour Medical Jiayuan No.1 Employee Stock Ownership Collective Asset Management Plan 1.45 2.50%
Ligong Hu 0.93 1.61%
HuaTai Innovative Investment Co., Ltd. 0.73 1.25%
Ruoyu Zhao 0.59 1.02%
Dong Wu 0.59 1.02%
Yan Li 0.39 0.68%
As of May 17,2021

Legal Statement

All information contained herein is provided by the underlying company itself and is for informational purposes only, and nothing contained herein should be construed as investment advice, either on behalf of a particular security or an overall investment strategy. The Shanghai Stock Exchange does not guarantee its accuracy and reliability and shall under no circumstance be responsible or liable for any error or for any loss directly or indirectly arising from any inaccuracy or omission or from any decision, action or non-action based on or in reliance upon the information herein.

Users may view and download the information herein for personal and non-commercial use free of charge subject to the laws of the People's Republic of China and the Legal Statement. No part of the information herein may be copied, downloaded, stored in a retrieval system or transmitted in any form or by any means, rented, displayed, performed, reproduced, photocopied, altered, sold, broadcast, published or otherwise in whole or in part in any manner for commercial purposes, without the prior written consent of the Shanghai Stock Exchange.

Users are hereby reminded that the Legal Statement represents your legally binding agreement with the Shanghai Stock Exchange. By accessing or using this website, you are also signifying your agreement with and acceptance of all the contents in the Legal Statement. The Shanghai Stock Exchange reserves the right to amend and interpret the Legal Statement.